OWIM
ATRA icon

Old West Investment Management’s Atara Biotherapeutics ATRA Stock Holding History

Old West Investment Management’s Portfolio ATRA Stock Details ATRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-387
Closed -$384K – 74
2019
Q1 		$384K Hold
387
– – 0.14% 60
2018
Q4 		$335K Sell
387
-12
-3% -$11.1K 0.09% 64
2018
Q3 		$412K Sell
399
-2
-0.5% -$1.96K 0.17% 67
2018
Q2 		$368K Buy
401
+13
+3% +$14K 0.18% 65
2018
Q1 		$378K Sell
388
-372
-49% -$339K 0.22% 65
2017
Q4 		$344K Sell
760
-76
-9% -$28.1K 0.2% 61
2017
Q3 		$345K Sell
836
-72
-8% -$27.1K 0.18% 58
2017
Q2 		$317K Sell
908
-89
-9% -$34.3K 0.17% 61
2017
Q1 		$512K Buy
+997
New +$413K 0.27% 50

Other funds holding ATRA

BG
Baupost Group Boston, Massachusetts $5.42B AUM 22.93% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Old West Investment Management's ATRA Position: Q2 2019 in Review

Old West Investment Management sold out of Atara Biotherapeutics (ATRA) in Q2 2019, closing a stake of 387 shares — an estimated $384K sold.

Old West Investment Management first reported a position in ATRA in Q1 2017 and held it in 9 quarters. The position peaked at $512K in Q1 2017. 116 funds tracked by Wall St. Rank hold ATRA as of Q2 2019.

  • Old West Investment Management reported no remaining Atara Biotherapeutics position as of Q2 2019 after selling out during the quarter.
  • Old West Investment Management sold 387 Atara Biotherapeutics shares in Q2 2019, an estimated $384K.
  • Old West Investment Management first reported a position in Atara Biotherapeutics in Q1 2017 and held it in 9 quarters.
  • Old West Investment Management's Atara Biotherapeutics position peaked at $512K in Q1 2017.
  • 116 funds tracked by Wall St. Rank held Atara Biotherapeutics as of Q2 2019.

Based on Old West Investment Management's 13F filing for Q2 2019, filed 14 Aug 2019.